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Abstract
Background A functional population of adipocyte precursors, termed adipose-derived stromal/stem cells (ASCs), is crucial
for proper adipose tissue (AT) expansion, lipid handling, and prevention of lipotoxicity in response to chronic positive
energy balance. We previously showed that obese human subjects contain a dysfunctional pool of ASCs. Elucidation of the
mechanisms underlying abnormal ASC function might lead to therapeutic interventions for prevention of lipotoxicity by
improving the adipogenic capacity of ASCs.
Methods Using epigenome-wide association studies, we explored the impact of obesity on the methylation signature of
human ASCs and their differentiated counterparts. Mitochondrial phenotyping of lean and obese ASCs was performed.
TBX15 loss- and gain-of-function experiments were carried out and western blotting and electron microscopy studies of
mitochondria were performed in white AT biopsies from lean and obese individuals.
Results We found that DNA methylation in adipocyte precursors is significantly modified by the obese environment, and
adipogenesis, inflammation, and immunosuppression were the most affected pathways. Also, we identified TBX15 as one of
the most differentially hypomethylated genes in obese ASCs, and genetic experiments revealed that TBX15 is a regulator of
mitochondrial mass in obese adipocytes. Accordingly, morphological analysis of AT from obese subjects showed an
alteration of the mitochondrial network, with changes in mitochondrial shape and number.
Conclusions We identified a DNA methylation signature in adipocyte precursors associated with obesity, which has a
significant impact on the metabolic phenotype of mature adipocytes.
Introduction
Obesity has become a major public health concern as it is a
risk factor for several diseases, including type 2 diabetes
(T2D), cardiovascular diseases and some forms of cancer. It
is now recognized that obesity, which has been traditionally
viewed as arising primarily from an imbalance between
energy intake and expenditure favoring fat storage, results
from interactions between environmental and genetic fac-
tors. Indeed, a growing body of evidence supports epige-
netics as a key mechanistic mediator of gene−environment
interactions underlying obesity and its comorbidities [1].
White adipose tissue (WAT) is conceivably the most
plastic organ in the body. In response to a chronic positive
energy balance, WAT expands by increasing the volume of
preexisting adipocytes (hypertrophy), and by generating
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new adipocytes (hyperplasia) through the recruitment of
adipocyte progenitors termed adipose-derived stromal/stem
cells (ASCs), which reside in perivascular WAT stroma.
ASCs undergo adipogenesis and differentiate into mature
adipocytes to maintain adipocyte turnover under a normal
metabolic state [2]. Available information suggests that
WAT homeostasis is perturbed in an obesogenic context
because of dysregulated adipogenesis [3], supporting the
concept that ASCs are important players in WAT remo-
deling during obesity [4].
We and others have demonstrated that subcutaneous
adipose tissue (SAT) from obese subjects contains a dys-
functional pool of human ASCs (hASCs). Accordingly,
there is evidence for an association between obesity and
loss of hASC multipotency [5], increased hASC prolifera-
tion [6], resistance to apoptosis [7], and reduced adipogenic
potential [6, 8]. Moreover, a recent study from our group
showed that the metabolic phenotype of the donor com-
promises the immunomodulatory properties of hASCs [9].
Stem cell differentiation is guided by epigenetic pro-
cesses that confer a specific chromatin conformation on the
genome [10]. Among the best characterized of these are
post-translational modifications of histone tails and CpG
dinucleotide methylation. Adult stem cells of different ori-
gin (e.g., WAT and bone marrow) exhibit a range of dif-
ferentiation potentials to mesodermal, endodermal, and
ectodermal tissues, and strong methylation of lineage-
specification promoters restricts their ability to differentiate,
underlining the existence of specific epigenetic profiles
associated with different degrees of differentiation potential
[11]. Alterations in DNA methylation during differentiation/
adipogenesis of hASCs, either under physiological or
pathological conditions, have been poorly explored. Indeed,
only a few adipogenic genes have been examined for
methylation of CpG islands to date [12], and only one study
has reported the DNA methylation profile of hASCs during
differentiation, specifically osteogenic and myogenic dif-
ferentiation [11]. We hypothesized that an obese environ-
ment would influence the methylation status of genes in
hASCs, which might contribute to the contrasting differ-
entiation and functional capacities of adult adipocytes to
promote dysfunctional WAT that is associated with
enhanced susceptibility to certain comorbidities such as
T2D [13]. In line with this, it has been recently described
that epigenetics plays a role in the development of adipose
tissue dysfunction in obesity [14]. Here, using epigenome-
wide association studies, we show that whereas the DNA
methylation signature remains relatively static during the
transition of hASCs to fully mature adipocytes, it is sig-
nificantly modified by an obese environment, supporting the
view that hASC dysfunction is a key regulatory event in
obesity. We also demonstrate that the methylation status of
TBX15, a transcription factor of the T-box family involved
in adipogenesis, fat distribution and browning [15–17],
might play an essential role in the mitochondrial phenotype
of WAT in obesity.
Materials and methods
Study subjects
For epigenetic-wide association studies (EWAS), hASCs
were obtained from SAT of healthy female donors under-
going elective liposuction surgery (cohort I): n= 6 lean,
BMI 22.4 ± 12 kg/m2, age 44.3 ± 9.2 years; n= 6 obese,
BMI 32.6 ± 2.2 kg/m2, age 34.3 ± 7.4 years (LaCell LLC,
New Orleans). Donors were classified as lean or obese
based on BMI following World Health Organization cri-
teria. All participants gave their informed consent and the
study was reviewed and approved by the Western Institu-
tional Review Board (Puyallup, WA, USA; Protocol #
201304490).
For other molecular analyses, hASCs were isolated from
SAT of age- and sex-matched donors undergoing nonacute
surgical interventions, such as hernia or cholecystectomy, in
a scheduled routine surgery (cohort II): n= 4 lean, BMI
23.7 ± 1.1 kg/m2, age 52.8 ± 11.5 years; n= 4 obese, BMI
32.4 ± 3 kg/m2, age 52 ± 10.5 years. All participants gave
their informed consent and the study was reviewed and
approved by the ethics and research committee of Uni-
versity Hospital Joan XXIII, Tarragona, Spain.
DNA methylation profiling using universal bead
array
Genomic DNA was extracted from cells using the
NucleoSpin® Tissue Kit (Macherery-Nagal GmbH). DNA
methylation profiles were generated on the Infinium
Human-Methylation450K BeadChip (Illumina). The Bead-
Chip was developed to assay more than 480,000 CpG sites
and selected CpG loci in parallel. DNA methylation data
were processed using GenomeStudio software (Illumina) by
applying the default settings. Methylation data is in the
GEO database with the accession code GSE111632.
Methylation data analysis
All computations and statistical analyses were performed
using R 3.0.2 and Bioconductor 2.13. Analysis of the
beadchip was performed using BiSeq 1.8.0 package [18],
which involved the following stages: creation of an object
of the Bssraw class (container of the raw data), CpG cluster
identification, methylation ratio smoothing in each CpG
cluster identified, test and model group effect for each CpG
site inside of CpG clusters, test CpG clusters for differential
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methylation and identification of differentially methylated
sites (DMSs) [19]. Smoothing criteria was performed using
90% quantiles, and CpG clusters considered for DMS
identification were filtered using a false discovery rate
<10% and with at least one differentially methylated posi-
tion. The β value, which represents the percentage of
methylation at each CpG site, was calculated from the
normalized intensity value. The Δβ or log 2-fold change
values at all CpGs sites from the different comparisons
(undifferentiated minus differentiated state or lean minus
obese condition) were analyzed using unpaired Student’s t
test and results with p values < 0.0001 were further
investigated.
Gene ontology analysis
Gene ontology (GO) analysis of the selected differentially
methylated regions was performed using Ingenuity Pathway
Analysis (IPA, Qiagen) and Panther [20].
Gene expression analysis
Total RNA was extracted from hASCs using the RNeasy
Mini Kit (Qiagen). One microgram of RNA was reverse
transcribed with random primers using reverse transcriptase
(Applied Biosystems). Quantitative gene expression was
evaluated by qPCR on a 7900HT fast real-time PCR system
using hydrolysis probes gene expression assays (Supple-
mentary Table S1). The relative expression of each tran-
script was measured using the 2−ΔΔCt method. Endogenous
18s RNA was used for normalization of gene expression
levels and calculation of ΔCt values. Values are expressed
as mean ± SEM. Data were analyzed using Excel and
GraphPad Prism software 5. Differences were considered
statistically significant if the p value was <0.05 (t test).
Statistical analyses
The sample size of the epigenetic study was calculated to
detect differences for methylation levels taking into account
published values of epigenome-wide analysis in the field of
stem cells [11, 21]. Data are presented as mean (SEM) or
median (25th–75th) quartiles as appropriate. Before statis-
tical analysis, normal distribution and homogeneity of the
variances were evaluated using Levene’s test. Student’s
paired two-sample t test and NPAR test (Wilcoxon) were
used for anthropometric and biochemical variables. Mann
−Whitney test was used to compare groups of adipose
tissue samples and Student’s paired two-sample t test was
used for the in vitro data. All experimental results were
from 3−4 independent experiments performed at least in
duplicate. The relationship between quantitative variables
was tested using Pearson’s test and correlations with
Spearman’s analysis. Statistical analyses were performed
using the program SPSS (version 15.0).
Results
Impact of obesity on global DNA methylation
patterns in hASCs and differentiated adipocytes
As a first step to investigate the potential contribution of
obesity to DNA methylation and adipocyte differentiation,
hASCs were isolated from the SAT compartment of lean
and obese subjects (n= 6; as described in Materials and
methods). Isolation and differentiation of hASCs to mature
adipocytes was performed as described [6, 9]. We extracted
genomic DNA from cells before and after differentiation
and performed EWAS on the Illumina platform using the
Infinium Human-Methylation450K BeadChip array
(Fig. 1a). We established a threshold of log 2-fold change
with a p value < 0.0001 to discern DMSs between the
conditions. At the global level, only 0.01% of the CpG sites
studied displayed changes between differentiation states,
whereas this rose to 0.2% when lean and obese conditions
were considered. We identified 650 DMSs between hASCs
from lean and obese subjects and only 206 DMSs between
equivalent mature adipocytes (Fig. 1a, b), with a total of 64
DMSs in common. In lean subjects, 43 DMSs were iden-
tified between hASCs and differentiated adipocytes,
whereas 34 DMSs were identified in obese subjects
(Fig. 1a). Overall, these data show that the methylome is
comparatively stable between hASCs and mature adipo-
cytes, and also that the majority of the differences detected
are due to the obese environment already established in the
hASC niche. The apparent discordance between the number
of DMSs in hASCs and adipocytes according to phenotype
(lean vs. obese) can be explained because of the use of an
arbitrary cutoff (see Materials and methods), which could
have led to small changes not identified as statistically
different DMSs. Nevertheless, β value differences between
lean and obese donors showed a strong correlation for
DMSs both in ASCs (n= 650) and in adipocytes (n= 206),
but not for a subset of randomly selected probes (n= 1000)
(Supplementary Figure S1). This indicates that DMSs
between lean and obese are largely maintained in both
ASCs and adipocytes, even when the p value does not reach
the threshold (0.0001). Also, since global methylation is
known to increase during differentiation, this may have
conceivably masked small changes occurring during the
differentiation of hASCs to mature counterparts. Interest-
ingly, global methylation levels were significantly lower in
obese-derived hASCs than in lean-derived counterparts
(Fig. 1c). Moreover, 88.37% (38 from 43 DMSs) of the
methylation changes that occurred during adipogenesis
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Fig. 1 Obesity modifies the hASC methylome. a Schematic repre-
sentation of the approach performed and the main results obtained (p <
0.0001). b Manhattan plots (−Log10(p) genome-wide association
plot). All DMSs achieving the significance threshold are colored in
green (p < 0.0001). c Global methylation status of ASCs and mature
counterparts. Results are shown as mean ± SEM. t test; *p < 0.05,
***p < 0.001 vs. lean-derived hASCs; ###p < 0.001 vs. obese-derived
hASCs. d Supervised cluster analysis and heat map showing the dif-
ferential groups of CpGs according to their methylation profile in all
analyzed samples. n= 6, patients per group. hASCs human adipose-
derived stem cells, AD adipocyte, DMS differentially methylated site
(color figure online)
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were hypermethylation events. We next analyzed hier-
archically all the CpG methylation differences observed
between lean and obese states. Supervised cluster analysis
and heat map analysis revealed that the CpG sites analyzed
segregated into two clusters, and indicated that only a small
proportion of the CpG sites had a low degree of methylation
(Fig. 1d).
We next segmented the four methylomes into three
classes: fully methylated regions (FMRs; >50% methylated
CpGs), low methylated regions (LMRs; <13.9–50%) and
unmethylated regions (UMRs; <13.9%), as previously
described [22, 23]. The FMR class comprised over 50% of
the methylome in all samples (Fig. 2a), and the global
percentage of methylation was stable between lean and
obese hASCs. By contrast, when we compared adipocytes
differentiated from hASCs of lean and obese subjects, we
found a global increase in methylation in the latter, with an
important gain in FMRs (overall increase of 16%) and a
decrease in the number of UMRs. Several studies suggest
that the effects of DNA methylation on gene expression are
highly dependent on the genomic location of the CpG
dinucleotide [22, 24]. To assess whether differential
methylation is preferentially allocated at specific genomic
regions, we classified all DMSs into seven categories of
genome annotations: located in promoters–transcription
start site (TSS) (a) −200 bp (TSS200) and (b) −1500 bp
(TSS1500); (c) intergenic region (IGR); located in intra-
genic regions (d) 1st exon, (e) gene body, (f) 3′UTR, and
(g) 5′UTR. The majority of changes found in hASCs were
those located in transcribed regions (body), which have
been shown to positively correlate with transcribed genes
[24] (Fig. 2b, left panel). While a similar tendency was
observed in mature adipocytes, we detected an approximate
twofold increase in the location of DMSs at distal promoters
(TSS1500) where DNA methylation is normally negatively
correlated with gene expression (Fig. 2b, left panel). The
DMS distribution within a CpG island (island>shelf>shor-
e>open sea) is depicted in Fig. 2b, right panels. In both
settings, 67% of the significant changes were found in the
most distal areas from a CpG island (shore and open sea).
Overall, the above data show that hASCs are obesity-
conditioned through the accumulation of epigenetic mod-
ifications, at least at the level of DNA methylation, which
might underlie the altered plasticity of obese-derived hASCs
as previously reported by us [6, 9] and others [8, 25]. In an
attempt to discern which molecular pathways might be influ-
encing the hASC niche in an obese environment, we per-
formed a functional analysis by GO enrichment using the
Ingenuity database for all genes containing DMSs. Since
we were specifically interested in the functionality of adipo-
cyte precursors as key determinants of adipose tissue expan-
sion, we focused on changes in the hASC compartment. As
anticipated, GO analysis identified gene functions associated
with adipogenesis (Fig. 2c). Other differentially enriched bio-
logical pathways detected included inflammation (LPS/IL-1)
and immunosuppression/repair (TFG-β). These findings are in
Fig. 2 DNA methylation changes during adipocyte differentiation. a
The percentage of DMSs distributed into three classes: fully methy-
lated regions (FMRs > 50% methylated CpGs); low methylated
regions (LMR, 13.9–50%); and unmethylated regions (UMRs <
13.9%). b DMS distribution and CpG allocation. c Pathway analysis
for genes associated with DMSs in hASCs
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agreement with our earlier studies showing that hASCs
from obese patients have a heightened inflammatory
profile and reduced immunosuppressive properties [6, 9],
and are consistent with results from other independent studies
[26, 27].
Influence of epigenetic signature on gene
expression in hASCs
To explore in more detail the methylation changes in lean-
and obese-derived hASCs, we first used a more restrictive
cutoff to exclude all sites with less than 20% methylation
change and to give us a more manageable number, which
reduced the list from 650 DMSs to 60. The top ten genes
with the greatest DNA methylation changes (hyper- and
hypomethylated) are shown in Table 1. DNA methylation is
most often linked to gene silencing. From the eight genes
screened to evaluate the correlation between methylation
status and mRNA expression, the expected inverse rela-
tionship between gene expression and methylation level
was established for five of them: TBX15, PRDM16, ACLY,
GLI2, and LSP1 (Fig. 3a). In the remaining three genes
(POU3F3, CCL4, CDKN1A), an increase in methylation in
obese hASCs was associated with higher mRNA levels
(Fig. 3a). As the genomic location of DMSs might con-
tribute to explain these divergences, we next examined this
finding that DNA methylation around promoter and intra-
genic regions negatively correlated with gene expression
(Table 1 and Fig. 3a). For example, TBX15 was demethy-
lated to different degrees in obese hASCs as compared with
lean counterparts, which was accompanied by upregulation
at the mRNA level. By contrast, DMSs around the IGR did
not trigger a direct modification at the mRNA level. This
was the pattern observed for CCL4, CDKN1A, and
POU3F3 in which the occurrence of methylated DMSs
located in the IGR (Table 1) did not correlate with
Table 1 Top 10 hypo- and hyper-methylated sites with more of 20% of change
TOP 10 HYPO-METHYLATED
logFC ProbeID p-value CHR DMSs Gene Localizaon Biological Funcon
1 -0.41 cg16990168 8.14E-05 1 13 TBX15 5'UTR - shore Developmental process, adipogenesis
-0.32 cg05172122 2.06E-04 5'UTR - island
-0.31 cg19730691 9.46E-05 5'UTR - shore
-0.31 cg08942939 2.41E-04 TSS1500 - shore
-0.30 cg00466334 1.26E-04 TSS1500 - shore
-0.29 cg07892597 2.37E-04 1stExon - island
-0.29 cg22820316 1.53E-04 TSS1500 - shore
-0.29 cg12664119 2.14E-04 TSS200 - shore
-0.27 cg25340966 1.97E-04 TSS200 - island
-0.25 cg26272623 3.69E-04 TSS200 - shore
-0.24 cg14565725 2.85E-04 1stExon - island
-0.23 cg03760839 2.36E-04 5'UTR - shore
-0.20 cg24144440 1.34E-04 5'UTR - island
2 -0.38 cg05280794 2.43E-04 17 1 ABR Body - open sea Inflammatory response, migraon
3 -0.30 cg08944170 6.87E-05 1 1 OR2L13 1stExon - island G-protein coupled receptor signaling pathway
4 -0.28 cg07280807 1.06E-04 14 4 SMOC1 IGR - island Developmental process
-0.24 cg10399005 3.65E-05 IGR - island
-0.24 cg20475486 4.31E-05 IGR - island
-0.22 cg15361373 2.41E-04 IGR - shore
5 -0.24 cg13294084 4.48E-04 2 1 OTOS IGR - island Developmental process
6 -0.22 cg08800613 2.64E-05 2 1 PXDN IGR - island Inflammatory response, migraon
7 -0.21 cg14637685 2.37E-04 12 1 CACNA1C Body - open sea Insulin secreon, metabolic process
8 -0.21 cg01413848 9.88E-05 1 1 PRDM16 Body - island Adipogenesis
9 -0.20 cg09896340 3.29E-05 8 1 DLGAP2 IGR - shore Metabolic process
10 -0.20 cg11125758 1.49E-04 14 1 SEL1L IGR - open sea Metabolic process
TOP 10 HYPER-METHYLATED
1 0.33 cg25174111 4.38E-05 11 1 MUS81 Body - shelf Inflammatory response, migraon, metabolic process
2 0.30 cg07112473 2.09E-05 2 2 POU3F3 IGR - island Inflammatory response, migraon
0.24 cg22928386 3.17E-04 IGR - shore
3 0.29 cg15106294 2.34E-04 6 1 CDKN1A IGR - shelf Cell cycle
4 0.27 cg06956006 2.36E-04 17 1 ACLY Body - open sea Metabolic process
5 0.26 cg14624731 1.57E-06 2 1 GLI2 IGR - open sea Developmental process
6 0.25 cg05003723 2.12E-04 11 1 LSP1 Body - open sea Inflammatory response, migraon
7 0.25 cg04055096 4.93E-05 16 1 ZNF423 Body - open sea Developmental process
8 0.24 cg22327527 6.44E-05 7 1 AMPH Body - shore Endocytosis
9 0.24 cg07533249 2.42E-07 17 1 CCL4 IGR - open sea Inflammatory response, migraon
10 0.24 cg08576208 5.81E-05 4 2 MSX1 IGR - shore Developmental process
0.21 cg25142170 1.27E-05 IGR - shore
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downregulation of the mRNA (Fig. 3a). For the transcrip-
tion factor GLI2, we detected an increase in methylation
above 20% within an IGR; nevertheless, expression of this
gene was significantly decreased in obese hASCs. This
could be explained by the finding that GLI2 possesses other
significant DMSs in the gene body whose DNA methylation
levels were in agreement with its pattern of mRNA
expression (Supplementary Table S2).
Hypomethylation of mesodermal developmental
gene TBX15 in obese hASCs is associated with
mitochondrial function in mature adipocytes
We focused on TBX15 since it was highly regulated at the
epigenetic level, containing a total of 13 DMSs (Table 1 and
Supplementary Figure S2). TBX15 belongs to the T-box
family of homeodomain transcription factors, which are
essential for many developmental processes. The methyla-
tion levels of TBX15 were further validated by bisulfite
sequencing, confirming that the amplicon was demethylated
in obese hASCs (Supplementary Figure S3). The high
mRNA level of TBX15 in obese hASCs (Fig. 3a) was
confirmed at the protein level (Fig. 4a). Intriguingly,
whereas the protein levels of TBX15 were higher in obese
hASCs than in lean hASCs, its expression significantly
decreased throughout the adipogenic differentiation process
both in obese- and lean-derived cells, suggesting a devel-
opmental role for TBX15 in WAT adipogenesis. Even so,
TBX15 protein levels remained higher in mature adipocytes
from obese-derived hASCs than from those of lean subjects.
A previous study in murine adipocyte precursors indicated
that Tbx15 regulates brown but not white adipocyte dif-
ferentiation [17], whereas another study described Tbx15 as
a negative regulator of mitochondrial mass and adipogen-
esis in murine 3T3-L1 pre-adipocytes [15]. To explore the
effects of TBX15 on adipocyte precursors, we first trans-
fected obese-derived hASCs with a pool of three target-
specific siRNAs against TBX15 to silence its expression.
TBX15-silenced cells showed a significant decrease in the
expression of beige adipocyte markers (including TBX1 and
TMEM26), catalytic components of mitochondrial complex
I (NDUFA9) and II (SDHA), and mitochondrial fusion
Fig. 3 Differentially methylated sites have a differential effect on
mRNA expression. a Methylation and mRNA levels of TBX15,
PRDM16, ACLY, GLI2, LSP1, POU3F3, CCL4, and CDKN1A genes
in hASCs. Significant DMSs (#p < 0.0001) identified by EWAS are
shown (n= 6 patients per group). Verification of mRNA levels of
genes associated with the DMSs identified (n= 4 patients per group).
Results are shown as mean ± SEM. t test; *p < 0.05, **p < 0.01 vs.
lean hASCs. Gene name in green (decreased methylation and
increased mRNA expression), in orange (increased methylation and
decreased mRNA expression), and in blue (methylation and mRNA
expression incongruity) (color figure online)
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markers (including MFN2 and OPA1) (Fig. 4b), in part,
supporting the proposed role of TBX15 in the beiging of
SAT [17]. Remarkably, most of these genes were upregu-
lated in obese ASCs as compared with equivalent lean cells
(Supplementary Figure S4) which, considering the higher
levels of TBX15 in obese ASCs, supports its instructive role
in the mitochondrial phenotype of adipocytes. Additionally,
we detected a decrease in the expression of genes encoding
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proteins for fatty acid transport and oxidation (ACAA1,
CPT1A, CPT1B, SLC25A20), glucose uptake (GLUT4),
glycolysis (LDHA, LDHB) and the TCA cycle (OGDH,
PDH) in TBX15-silenced obese ASCs (Supplementary
Figure S5). Interestingly, most of these genes were also
found increased in obese compared with lean ASCs [9].
Overall, these results suggest a potential role for TBX15 in
the mitochondrial and/or metabolic phenotype of mature
adipocytes in an obesity context. Accordingly, down-
regulation of TBX15 expression in obese precursors before
inducing differentiation resulted in a decrease in the mito-
chondrial mass of mature adipocytes, pointing to a possible
reversal of the obese phenotype (Fig. 4c). Further, silencing
TBX15 expression did not affect adipocyte differentiation,
at least in terms of lipid content (Fig. 4d) and expression of
typical adipogenic markers (Fig. 4e). Conversely, when we
increased TBX15 expression in lean-derived ASCs with an
adenovirus vector, cells showed an upregulation of mito-
chondrial marker expression (Supplementary Figure S6),
and this was accompanied by an increase in mitochondrial
mass in lean-derived differentiated adipocytes (Fig. 4c).
Although we failed to detect significant changes in mito-
chondrial mass or respiratory capacity between obese- and
lean-derived hASCs (Supplementary Figure S7), mature
adipocytes from obese-derived hASCs exhibited a higher
mitochondrial respiratory capacity than those from equiva-
lent lean-derived cells (Fig. 4f). Overall, these results indi-
cate that TBX15 expression in human adipocyte precursors
establishes the mitochondrial phenotype of mature cells.
Mitochondrial phenotype of human subcutaneous
adipose tissue in obesity
To extend this analysis, we examined TBX15 expression in
SAT from lean and obese subjects. Several studies have
demonstrated obesity-triggered mitochondrial dysfunction
in WAT, both in clinical subjects and experimental models
[28, 29], but whether this is a cause or a consequence of the
disease process is unclear. Moreover, contrasting reports
have been published regarding depot-specific and obesity-
dependent expression of TBX15 [15, 16, 30], and its
potential modulation of mitochondrial metabolism [15, 16,
30]. Expression analysis of TBX15 in SAT from individuals
classified according to BMI (clinical and laboratory data
summarized in Supplementary Table S3) revealed sig-
nificantly higher TBX15 protein levels in obese than in lean
subjects (Fig. 5a). Consistent with the ability of TBX15 to
regulate the mitochondrial phenotype (Fig. 4), higher
TBX15 expression in obese SAT correlated with a sig-
nificant increase in the expression of several mitochondria-
related genes such as the oxidative phosphorylation sub-
units NDUFA9 (complex I), SDHA (complex II) and
COX4–1 (complex IV) (Fig. 5b). Interestingly, the
expression of the mitochondrial fusion proteins MFN2 and
OPA1 was also higher in mitochondria fractions of SAT
from obese subjects (Fig. 5b). We also detected a significant
increase in the expression of porin, a mitochondrial mass
indicator. Accordingly, expression of these proteins was
positively associated with BMI (Fig. 5c). Finally, we
examined mitochondrial morphology in SAT samples by
transmission electron microscopy (Fig. 5d). Results showed
that adipocytes from obese subjects had significant altera-
tions in mitochondrial morphology and size as compared
with those of lean individuals. Specifically, mitochondrial
number and area were significantly higher in obese-derived
SAT than in lean-derived SAT, whereas mitochondrial size
was significantly smaller (Fig. 5e). Since mitochondrial
function is closely linked both to mitochondrial shape and
the intracellular distribution of mitochondria, these changes
detected in obese WAT might be directly associated with
adipocyte energy disturbances linked to obesity.
Discussion
DNA methylation is one of the best studied epigenetic
mechanisms regulating gene transcription and encodes
genetic and environmental effects as stable chemical mod-
ifications of DNA. A better understanding of the epigenetics
of hASCs might help in the development of new strategies
designed to combat obesity and/or promote “healthy” WAT
expansion. In the present study, we show that the differ-
entiation of hASCs into mature adipocytes is reflected in a
discrete number of changes in DNA methylation. By con-
trast, the methylation signature of obese and lean hASCs is
widely different, presenting an unprecedented epigenetic
model for the general short circuit in the stemness network
of obese hASCs [5]. Accordingly, an obese environment
Fig. 4 Obesity impacts mitochondrial functionality in hASCs and in
differentiated adipocytes. a TBX15 protein levels in hASCs from lean
and obese subjects and in differentiated adipocytes (AD) (n= 3
patients per group). t test; #p < 0.05 vs. hASCs; *p < 0.05 vs. lean
cells. b hASCs isolated from obese subjects were transfected with
100 nM of siRNAs against TBX15 or control, followed by quantitative
PCR (qPCR) analysis of the expression of brown and beige markers,
mitochondrial redox carriers and mitochondrial fusion genes (n= 4
patients per group). t test; #p < 0.001 and *p < 0.05 vs. control cells. c
Mature adipocytes derived from obese TBX15-silenced hASCs or lean
hAScs overexpressing TBX15 were analyzed using Mitotracker
staining by flow cytometry; representative images are shown (n= 3) t
test; **p < 0.01 vs. obese control; #p < 0.05 vs. lean control. d
Quantification and representative intracellular lipid enrichment in
adipocytes derived from obese, obese TBX15-silenced and lean indi-
viduals (magnification, ×20). t test; *p < 0.05 vs. control obese cells. e
Gene expression analysis of adipogenic markers by qPCR in mature
obese adipocytes (n= 4 patients per group). t test; #p < 0.001 vs.
control obese cells. f Oxygen consumption in intact adipocytes was
measured by respirometry (n= 6 patients per group). Results are
shown as mean ± SEM. t test, *p < 0.05 vs. lean
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may imprint a specific epigenetic signature on adipocyte
precursors so they become dysfunctional adipocytes.
Against this background, a previous study from our group
revealed that obesity-related adipose tissue hypoxia is
necessary but not sufficient to orchestrate significant func-
tional changes in mature adipocytes [6].
Our genome-wide approach allowed us to define new
regulatory regions that are differentially methylated in
hASCs and that are associated with the control of critical
adipogenic differentiation genes. Many of the DMSs iden-
tified in the present study were located outside of a proximal
gene promoter or CpG island. Conventionally, methylation
on promoters blocks transcription whereas methylation in
the gene body does not block and might even stimulate
transcription [31]. Although the functional roles of gene
body DNA methylation are still a matter of debate [32], our
results suggest that gene body methylation has a direct
impact on gene expression.
Fig. 5 Mitochondrial phenotype of human subcutaneous adipose tissue
in obesity. a SAT of lean and obese subjects was subjected to
immunoblotting against TBX15. Representative immunobloting and
quantification is shown (n= 14 patients per group). Correlation
(Spearman’s analysis) between BMI and TBX15 protein expression is
also shown. b Mitochondrial fractions isolated from SAT of lean and
obese patients were subjected to immunoblotting with antibodies
against complex I (NDUFA9), complex II (SDHA), complex IV
(COX4-1), MFN2, OPA1, and PORIN. Ponceau S was used as a
loading control. A representative blot and densitometry analysis of 11
lean and 32 obese patients performed is shown. c Correlation
(Spearman’s analysis) between BMI and complex I (NDUFA9),
complex II (SDHA), complex IV (COX4-1), MFN2, OPA1, and
PORIN. d Transmission electron microscopy images of mitochondria
in SAT from lean and obese subjects. Representative images are
shown. Scale bars, 500 nm. Black arrows indicate mitochondria; C
Cytoplasm, L Lipid droplet. e Quantification of absolute mitochondrial
area vs. total cytoplasmatic area, number of mitochondria and mito-
chondrial area (n= 3 patients for each group). Values are expressed as
mean ± SEM. Mann−Whitney test; *p < 0.05; **p < 0.01; ***p <
0.001 vs. lean
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Other studies have explored the epigenetic state of
hASCs in relation to their differentiation potential, con-
cluding that DNA methylation reflects neither transcrip-
tional status nor potential for gene expression upon
differentiation [12, 33]. These studies were, however, per-
formed on a narrow set of adipogenic genes (LEP, PPARG,
FABP4, LPL), and despite the finding that methylation
levels were similar among clones, mRNA levels and hASC
differentiation potential to mature adipocytes were hetero-
geneous [12]. Moreover no consideration was given to other
types of stimuli that could epigenetically prime adipose
progenitors cells, such as donor metabolic status or obesity,
which may explain some of the differences observed
between clones. In line with our results, Moskaug and
colleagues [34] showed that exposure of hASCs to high
glucose upregulated inflammatory genes and altered histone
H3 methylation in a manner suggestive of transcriptional
de-repression. Clearly, further studies are needed to fully
characterize the obesity-linked factors underlying the epi-
genetic signature of hASCs, as well as the potential rever-
sibility of the process.
Adipose tissue from obese individuals and patients with
T2D contains a dysfunctional pool of hASCs [8, 9]. To the
best of our knowledge, the present study is the first to
establish that the pathological adaptation of hASCs in an
obese context is regulated, at least in part, at the epigenetic
level. In support of this notion, Ollikainen and colleagues
[27] performed an extensive examination of genome-wide
DNA methylation in SAT from monozygotic twins with
discordant BMI, finding an upregulation of inflammation
and extracellular matrix remodeling genes accompanied by
a downregulation of adipogenic genes. Although little is
known about the molecular mechanisms that go awry in
obesity, it is clear that they may be epigenetically regulated
prior to disease development. Alterations in SAT are com-
monly associated with the development of unhealthy obe-
sity, and our study provides evidence for hASC epigenetic
dysfunction as a potential key regulatory event in obesity
that results in impaired maturation of adipocytes.
Of the 650 CpGs differentially methylated between lean
and obese hASCs, 13 were related to the transcription factor
TBX15. This gene is known to play a major role in meso-
dermal development in all vertebrates [15]; however, its role
in WAT is controversial. Accordingly, it has been described
that obesity can both increase [30] and decrease [35] TBX15
mRNA expression. Additionally, opposing functions have
been attributed to TBX15 with respect to adipogenesis and
mitochondrial activity [15, 17].
We show that TBX15 is hypomethylated at multiple CpG
sites in obesity and its expression is upregulated in hASCs
and SAT from obese subjects. Moreover, TBX15 is highly
expressed in hASCs and its expression is reduced during
differentiation, suggesting an important developmental role.
Indeed, Tbx15 depletion studies in murine adipose tissue-
derived cells have demonstrated an essential role for Tbx15 in
the development of adipogenic and thermogenic programs in
adipocytes [17]. By contrast, studies using the murine pre-
adipocyte cell line 3T3-L1 showed that Tbx15 overexpression
inhibited adipogenesis and mitochondrial respiration [15]. We
show here that TBX15 expression in hASCs directly influ-
ences the phenotype of mature adipocytes. Obese-derived
hASCs silenced for TBX15 expression have decreased
mRNA levels of mitochondrial and metabolic markers and,
when induced to differentiate, have a diminished mitochon-
drial mass. Obese-derived adipocytes showed higher respira-
tory capacity than lean counterparts and SAT of obese
individual displayed an increased mitochondrial mass with a
concomitant increase in the expression of several respiratory
chain proteins. Although some studies have reported a
decrease in the respiratory capacity of SAT in obesity [36,
37], other studies are in agreement with our present results
[38, 39]. While it is believed that reduced mitochondrial
function is a hallmark of human obesity [28], several con-
siderations need to be taken into account: most of the studies
have been performed on isolated mitochondria where the
mitochondrial communication network is completely lost,
whereas our study used intact cells. Furthermore, although
mitochondrial DNA has been extensively used as an index of
mitochondrial content, relevant physiological and pathophy-
siological interpretation of the data could be misconstrued
depending on the factor used for normalization, as stated by
Dela and colleagues [40]. Additionally, ours is the only study
that has used electron microscopy to analyze the mitochon-
drial network in SAT.
It is important to mention that we examined the effect of
mild obesity (mean BMI of 30 kg/m2) on mitochondrial
function, in which a compensatory response of the fat cell
could be occurring. Thus, mild obesity might impair mito-
chondrial function, but the adipocyte could counteract this by
increasing the number of mitochondria. It is known that
mitochondria can adapt upon endocrine or metabolic chal-
lenge (termed mitochondrial plasticity), to meet their bioe-
nergetic demands. Elongation of mitochondria is a result of
increased fusion or decreased fission activity, typical for states
of increased energy efficiency (e.g., starvation or senescence).
Along these lines and in agreement with our results, short-
ening of mitochondria is the result of decreased fusion activity
or increased fission activity, which is typical for states of
reduced bioenergetic efficiency such as an oversupply condi-
tion like obesity [41]. Indeed, as obesity induces a switch from
glucose to lipid oxidation, a less efficient process in terms of
ATP production, it is not unreasonable to consider that in the
initial stages of obesity the fat cell attempts to compensate for
this by increasing the number of mitochondria.
In conclusion, we show that the methylation status of
adipocyte precursors is significantly modified by an obese
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environment and might determine mitochondrial function of
adipose tissue, supporting hASC dysfunction as a key reg-
ulatory event in obesity. Overall, our data strongly suggest
that although DNA methylation patterns are essentially
preserved during adipose tissue lineage commitment, obe-
sity preconditions hASCs with a dynamic loss of DNA
methylation in selected regions that may ultimately cause
WAT dysfunction and the development of metabolic syn-
dromes in obesity.
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